Bio-Techne Corp (NASDAQ: TECH) stock closed at 66.5 per share at the end of the most recent trading day (a -0.97% change compared to the prior day closing price) with a volume of 1.04M shares and market capitalization of 10.57B. Is a component of S&P 500, Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 3000 people. Bio-Techne Corp CEO is Charles R. Kummeth.

The one-year performance of Bio-Techne Corp stock is -13.77%, while year-to-date (YTD) performance is -19.76%. TECH stock has a five-year performance of 40.24%. Its 52-week range is between 65.77 and 90.6325, which gives TECH stock a 52-week price range ratio of 4.14%

Bio-Techne Corp currently has a PE ratio of 46.20, a price-to-book (PB) ratio of 7.40, a price-to-sale (PS) ratio of 15.53, a price to cashflow ratio of 40.50, a PEG ratio of 4.40, a ROA of 13.66%, a ROC of 14.64% and a ROE of 18.59%. The company’s profit margin is 25.22%, its EBITDA margin is 40.50%, and its revenue ttm is $848.26 Million , which makes it $5.40 revenue per share.

Of the last four earnings reports from Bio-Techne Corp, there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $0.40 for the next earnings report. Bio-Techne Corp’s next earnings report date is 07th Nov 2023.

The consensus rating of Wall Street analysts for Bio-Techne Corp is Strong Buy (1.36), with a target price of $106.73, which is +59.78% compared to the current price. The earnings rating for Bio-Techne Corp stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Bio-Techne Corp has a dividend yield of 0.38% with a dividend per share of $0.32 and a payout ratio of 27.00%.

Bio-Techne Corp has a Sell technical analysis rating based on Technical Indicators (ADX : 12.04, ATR14 : 1.79, CCI20 : -122.72, Chaikin Money Flow : -0.22, MACD : -2.92, Money Flow Index : 38.96, ROC : -9.71, RSI : 24.34, STOCH (14,3) : 6.77, STOCH RSI : 0.00, UO : 36.99, Williams %R : -93.23), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Bio-Techne Corp in the last 12-months were: Charles Kummeth (Option Excercise at a value of $10 856 251), Charles Kummeth (Sold 322 shares of value $26 726 ), Charles R. Kummeth (Option Excercise at a value of $10 856 251), Kelderman Kim (Sold 0 shares of value $-99 960 ), Nusse Roeland (Option Excercise at a value of $349 600), Nusse Roeland (Sold 8 939 shares of value $717 981 )